• ABOUT
  • UNBUZZD™
  • LUCID-MS
  • INVESTORS
  • TEAM
  • NEWS & EVENTS
  • QUANTUM VS BANKS
  • WHISTLEBLOWER POLICY
  • CONTACT
NASDAQ:QNTM
CSE:QNTM | FRA:0K91
Logo of Quantum Biopharma. Click to go to a Home page
NASDAQ:QNTM | CSE:QNTM | FRA:0K91
Logo of Quantum Biopharma. Click to go to a Home page
  • ABOUT
  • UNBUZZD™
  • LUCID-MS
  • Investors
  • TEAM
  • NEWS & EVENTS
  • QUANTUM VS BANKS
  • WHISTLEBLOWER POLICY
  • CONTACT

Corporate Governance

☰  IR MENU
  • Investors
  • Events
  • Press Releases
  • Financials & Filings
    • SEC Filings
    • Financial Results
    • Annual Reports
    • SEDAR+
    • Annual General Meeting Materials
  • Stock Info
  • Governance
  • Investor FAQ
  • Email Alerts
  • Investors
  • Events
  • Press Releases
  • Financials & Filings
    • SEC Filings
    • Financial Results
    • Annual Reports
    • SEDAR+
    • Annual General Meeting Materials
  • Stock Info
  • Governance
  • Investor FAQ
  • Email Alerts

Code of Conduct and Ethics

Download PDF

Nasdaq Corporate Governance Disclosure Statement

Download PDF

Board Diversity Matrix 2024

Download PDF

Board Diversity Matrix 2023

Download PDF

Board Diversity Matrix 2022

View Matrix
A blue and white dna molecule on a white background.

© Copyright 2025 Quantum BioPharma. All Rights Reserved. Powered by ACCESS Newswire.

Investor Relations

IR@QuantumBioPharma.com

General Inquiries

www.quantumbiopharma.com/contact

info@quantumbiopharma.com

+1-833-571-1811

Principal Executive Office

1 Adelaide Street East, Suite 801

Toronto, Ontario M5C 2V9

Email Alerts

Sign Up Today
Share by: